Cephalon seeks FDA approval for cancer painkiller
The tablet delivers the opioid painkiller through the oral mucus membrane utilizing a proprietary enhanced absorption technology. “Expanding our pain care franchise is integral to Cephalon’s growth strategy,”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.